Evidence map›Paper›PMID 35752584›Full record

ArticleArchives of cardiovascular diseases

Cardiopulmonary predictors of mortality in patients with COVID-19: What are the findings?

Hoda Kavosi, Sepehr Nayebi Rad, Reza Atef Yekta, Zahra Tamartash, Mahboubeh Dini, Zahra Javadi Nejad, Leila Aghaghazvini, Ali Javinani, Amir Mohammad Mohammadzadegan, Seyedeh Zahra Fotook Kiaei

Abstract read
In one paragraph

Article in Archives of cardiovascular diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hoda KavosiRheumatology Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
Sepehr Nayebi RadStudents' Scientific Research Centre (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
Reza Atef YektaDepartment of Anaesthesiology, Tehran University of Medical Sciences, Tehran, Iran.
Zahra TamartashRheumatology Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
Mahboubeh DiniNon-Communicable Disease Centre, Ministry of Health and Medical Education, Tehran, Iran.
Zahra Javadi NejadRheumatology Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
Leila AghaghazviniDepartment of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Ali JavinaniRheumatology Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
Amir Mohammad MohammadzadeganRheumatology Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
Seyedeh Zahra Fotook KiaeiAdvanced Thoracic Research Centre, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: Zfkiaee@sina.tums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince 2019, coronavirus disease 2019 (COVID-19) has been the leading cause of mortality worldwide.

aimsTo determine independent predictors of mortality in COVID-19, and identify any associations between pulmonary disease severity and cardiac involvement.

methodsClinical, laboratory, electrocardiography and computed tomography (CT) imaging data were collected from 389 consecutive patients with COVID-19. Patients were divided into alive and deceased groups. Independent predictors of mortality were identified. Kaplan-Meier analysis was performed, based on patients having a troponin concentration>99th percentile (cardiac injury) and a CT severity score ≥18.

resultsThe mortality rate was 29.3%. Cardiac injury (odds ratio [OR] 2.19, 95% confidence interval [CI] 1.14-4.18; P=0.018), CT score ≥18 (OR 2.24, 95% CI 1.15-4.34; P=0.017), localized ST depression (OR 3.77, 95% CI 1.33-10.67; P=0.012), hemiblocks (OR 3.09, 95% CI 1.47-6.48; P=0.003) and history of leukaemia/lymphoma (OR 3.76, 95% CI 1.37-10.29; P=0.010) were identified as independent predictors of mortality. Additionally, patients with cardiac injury and CT score ≥ 18 were identified to have a significantly shorter survival time (mean 14.21 days, 95% CI 10.45-17.98 days) than all other subgroups. There were no associations between CT severity score and electrocardiogram or cardiac injury in our results.

conclusionsOur findings suggest that using CT imaging and electrocardiogram characteristics together can provide a better means of predicting mortality in patients with COVID-19. We identified cardiac injury, CT score ≥18, presence of left or right hemiblocks on initial electrocardiogram, localized ST depression and history of haematological malignancies as independent predictors of mortality in patients with COVID-19.

Indexed as

COVID-19Heart InjuriesHospital MortalityHumansLungRetrospective StudiesSARS-CoV-2Tomography, X-Ray ComputedAtteinte myocardiqueCardiac injuryCOVID-19CT scoreÉlectrocardiogrammeElectrocardiographyÉlévation de la troponineScore calcique pulmonaireTroponin

Identifiers

PMID35752584
PMCPMC9174274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.